Subscribe
Search
News & Politics
Culture
Food
Science & Health
Money
Life Stories
Video
Reviews
Lifestyle
The New Sober Boom
Getting Hooked on Quitting
Education
Liberal Arts Cuts Are Dangerous
Is College Necessary?
Finance
Dying Parents Costing Millennials Dear
Gen Z Investing In Le Creuset
Crypto
Investing
SEC vs Celebrity Crypto Promoters
‘Dark’ Personalities Drawn to BTC
News & Politics
Culture
Food
Science & Health
Money
Life Stories
Video
Reviews
Lifestyle
The New Sober Boom
Getting Hooked on Quitting
Education
Liberal Arts Cuts Are Dangerous
Is College Necessary?
Finance
Dying Parents Costing Millennials Dear
Gen Z Investing In Le Creuset
Crypto
Investing
SEC vs Celebrity Crypto Promoters
‘Dark’ Personalities Drawn to BTC
Subscribe
Help keep Salon independent
Newsletter
News & Politics
Culture
Food
Science & Health
Money
Video
Search
Sydney Lupkin
Advertisement:
FDA keeps brand-name drugs on a fast path to market ― despite manufacturing concerns
Sydney Lupkin
5 things we found in the FDA’s hidden device database
Sydney Lupkin
Consumers rejected drug plan that mirrors Trump administration proposal
Sydney Lupkin
Trump administration salutes parade of generic drug approvals, but hundreds aren’t for sale
Sydney Lupkin, Jay Hancock
Pfizer settles kickback case related to copay assistance for $24M
Sydney Lupkin
Drugmakers blamed for blocking generics have jacked up prices
Sydney Lupkin
Patients overpay for prescriptions 23% of the time, analysis shows
Sydney Lupkin
Drugmakers dramatically boosted lobbying spending in Trump’s first quarter
Sydney Lupkin
This is an alert message.
OK